Approval · Notice of Compliance 28281 · 2022
VABYSMO: Notice of Compliance 28281
Issued May 27, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28281
- Date
- May 27, 2022
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VABYSMO | 02527618 | Marketed |
Medicinal ingredients
- FARICIMAB 6 MG per 0.05ML